Compare · BMGL vs PRVA
BMGL vs PRVA
Side-by-side comparison of Basel Medical Group Ltd (BMGL) and Privia Health Group Inc. (PRVA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BMGL and PRVA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- PRVA is the larger of the two at $2.73B, about 266.5x BMGL ($10.2M).
- Over the past year, BMGL is down 85.5% and PRVA is down 7.3% - PRVA leads by 78.1 points.
- PRVA has been more active in the news (11 items in the past 4 weeks vs 1 for BMGL).
- PRVA has more recent analyst coverage (25 ratings vs 0 for BMGL).
- Company
- Basel Medical Group Ltd
- Privia Health Group Inc.
- Price
- $0.62+9.58%
- $21.53-0.44%
- Market cap
- $10.2M
- $2.73B
- 1M return
- -12.07%
- -10.14%
- 1Y return
- -85.46%
- -7.34%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2021
- News (4w)
- 1
- 11
- Recent ratings
- 0
- 25
Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Latest BMGL
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 3 filed by new insider Soong Kwek Yoon
- SEC Form 3 filed by new insider Lu Jianing Jn
- SEC Form 3 filed by new insider Chen Tony
- SEC Form 3 filed by new insider Chhoa Darren Yen Feng
- SEC Form 3 filed by new insider Tan Boon Chye
- SEC Form 3 filed by new insider Fung Keng Leong
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 6-K filed by Basel Medical Group Ltd
- Compliance With Nasdaq Periodic Filing Requirement
Latest PRVA
- Privia Health Enters New Jersey
- Director Soistman Francis S Jr was granted 8,463 shares (SEC Form 4)
- Director Berberian Lance was granted 8,463 shares, increasing direct ownership by 110% to 16,131 units (SEC Form 4)
- Director Cocozza Nancy G was granted 8,463 shares, increasing direct ownership by 25% to 42,814 units (SEC Form 4)
- Director Kimmet Pamela O was granted 8,463 shares, increasing direct ownership by 33% to 34,172 units (SEC Form 4)
- Director Mccarthy Thomas A was granted 8,463 shares, increasing direct ownership by 43% to 27,983 units (SEC Form 4)
- Director King David P was granted 8,463 shares, increasing direct ownership by 20% to 50,775 units (SEC Form 4)
- Director Ryu Jaewon was granted 8,463 shares, increasing direct ownership by 22% to 47,110 units (SEC Form 4)
- Director Morris Matthew Shawn was granted 8,463 shares, increasing direct ownership by 12% to 76,651 units (SEC Form 4)
- SEC Form 3 filed by new insider Soistman Francis S Jr